Biotech, like Tech, maybe be due for a rebound. The sector is being shorted.
I've been catching a falling knife with Nektar Theraputics. NKTR, 94% owned by institutions, 1% owned by insiders, 5% owned by suckers like me. Was a $100 stock, I took a position at $32, it's now the $10 range. It's in my speculation of my portfolio.
We've all been there.I bought some NKTR at $13 and wrote a Feb 18 $15 call for $1.90, thinking there was no way it could drop below $11 in a month.
LOL.